SARS-CoV-2 re-infection, vaccination and neutralizing antibodies

J Infect. 2022 Jun;84(6):e120-e121. doi: 10.1016/j.jinf.2022.02.033. Epub 2022 Mar 1.

Authors

Marco Bongiovanni¹, Elena Spada², Cristina De Angelis², Gianmaria Liuzzi³, Giuseppe Giuliani³

Affiliations

¹ Department of Medicine, Internal Medicine Unit, ASST Rhodense, Milan, Italy; Department of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano, Switzerland. Electronic address: Marco.Bongiovanni@eoc.ch.
² Department of Medicine, Internal Medicine Unit, ASST Rhodense, Milan, Italy.
³ Laboratory Medicine, ASST Rhodense, Milan, Italy.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Neutralizing*
Antibodies, Viral
COVID-19* / prevention & control
Humans
Reinfection
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Vaccination

Substances

Antibodies, Neutralizing
Antibodies, Viral
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2